Renal denervation: Paradise lost? Paradise regained?

1Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Renal denervation is a relatively recent concept whose initial promising results suffered a setback following the SYMPLICITY 3 trial, which did not show a significant blood pressure-lowering effect in comparison to sham. In this review article, we begin with the history including the physiological basis behind the concept of renal denervation. Furthermore, we review the literature in support of renal denervation, including the recently published SPYRAL HTN-OFF MED, which demonstrated significant blood pressure reduction in the absence of antihypertensive medication. We further touch upon the potential pitfalls and possible future directions of renal denervation.

Cite

CITATION STYLE

APA

Padmanabhan, D., Isath, A., & Gersh, B. (2018). Renal denervation: Paradise lost? Paradise regained? US Cardiology Review, 12(2), 78–86. https://doi.org/10.15420/usc.2018.1.2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free